Fairvalue-Calculator Fairvalue-Calculator
EN DE

1CM Inc (MILFF) Fair Value & Analysis

Healthcare · US · Market cap $4.0M

Price$0.0781
Fair Value$0.0640
Upside-18.1%
Quality95/100
Evidence: High Range $0.0562 – $0.0796

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

1CM Inc (MILFF) currently trades at $0.0781, while our model-based Fair Value estimate is $0.0640 — implying the stock looks roughly 18.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

1CM Inc., a multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada. The company operates cannabis and liquor retail stores. It also offers One Cannabis Market, a technology platform that provides B2B and B2C solutions, including last mile delivery, digital signage, big data analytics, and wholesale clearing services. The company was formerly known as Leviathan Natural Products Inc. and changed its name to 1CM Inc. in September 2022. 1CM Inc. is based in Markham, Canada.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is 1CM Inc (MILFF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0640 versus a price of $0.0781 — about −18% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MILFF?
Our 21-model fair value for 1CM Inc is $0.0640 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0781.
What is the quality score of MILFF?
1CM Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.